TY - JOUR
T1 - Comparison of methodologies for the detection of BRAF mutations in bone marrow trephine specimens
AU - Cardus, Beatrix
AU - Colling, Richard
AU - Hamblin, Angela
AU - Soilleux, Elizabeth
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Aims BRAF V600E detection assists in the diagnosis of hairy cell leukaemia (HCL); however, testing practices vary. We evaluated the clinical utility of 5 BRAF mutation testing strategies for use on bone marrow trephines (BMT). Methods 11 HCL, 5 HCL a € mimic', 2 treated HCL and 10 normal BMT specimens were tested for mutant BRAF, comparing Sanger sequencing, pyrosequencing, amplicon-based next generation sequencing (NGS), automated (Idylla) PCR and immunohistochemistry (IHC). Results PCR and IHC were cheaper and identified V600E in 100 % of HCL cases. Pyrosequencing detected the mutation in 91%, NGS in 55% of cases and Sanger sequencing in 27%. All assays gave wild-type BRAF results in HCL mimics and normal BMT samples. Conclusions PCR and IHC were most sensitive and cost-effective, but these have limited scope for multiplexing and are likely to be replaced by NGS gene panels or whole genome sequencing in the medium to long term.
AB - Aims BRAF V600E detection assists in the diagnosis of hairy cell leukaemia (HCL); however, testing practices vary. We evaluated the clinical utility of 5 BRAF mutation testing strategies for use on bone marrow trephines (BMT). Methods 11 HCL, 5 HCL a € mimic', 2 treated HCL and 10 normal BMT specimens were tested for mutant BRAF, comparing Sanger sequencing, pyrosequencing, amplicon-based next generation sequencing (NGS), automated (Idylla) PCR and immunohistochemistry (IHC). Results PCR and IHC were cheaper and identified V600E in 100 % of HCL cases. Pyrosequencing detected the mutation in 91%, NGS in 55% of cases and Sanger sequencing in 27%. All assays gave wild-type BRAF results in HCL mimics and normal BMT samples. Conclusions PCR and IHC were most sensitive and cost-effective, but these have limited scope for multiplexing and are likely to be replaced by NGS gene panels or whole genome sequencing in the medium to long term.
KW - bone marrow
KW - BRAF
KW - Hairy cell leukaemia
KW - immunohistochemistry
KW - molecular pathology
UR - https://www.scopus.com/pages/publications/85063014265
U2 - 10.1136/jclinpath-2019-205734
DO - 10.1136/jclinpath-2019-205734
M3 - Article
C2 - 30872385
AN - SCOPUS:85063014265
SN - 0021-9746
VL - 72
SP - 406
EP - 411
JO - Journal of Clinical Pathology
JF - Journal of Clinical Pathology
IS - 6
ER -